Phase 3 Study to Evaluate the Immunogenicity and Safety of Inactivated Split Influenza Vaccine in Healthy Korea Adults
Clinical trial NCT02154308 · COMPLETED
Trial details
- NCT number
- NCT02154308
- Sponsor
- Il-Yang Pharm. Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2012-11-01
- Primary completion
- 2013-03-01
- Enrollment
- 787
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.